December 6-7, 2024 | Dallas, TX |
This educational activity is specifically designed for physicians, nurse practitioners, physician assistants, nurses, and podiatrists involved and/or interested in the therapeutic management of patients with diabetic foot complications.
After completing this activity, participants should be able to:
This live program will occur on December 6 & 7, 2024.
To be eligible for documentation of credit for each session attended, participants must participate in the activity and complete the online general survey and the online evaluation by January 7, 2025. Upon completing the activity, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit.
For questions regarding this activity, please submit a request to contact the support team
In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity.
Provided by HMP Education, an HMP Global Company.
PHYSICIANS
HMP Education designates the live activity GDU in Diabetic Foot General Sessions for a maximum of 10 AMA PRA Category 1 Credit™.
HMP Education designates each live activity, Industry-Supported Symposium, for a maximum of 1 AMA PRA Category 1 Credit™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PHYSICIAN ASSOCIATES/ASSISTANTS
HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria.
GDU in Diabetic Foot General Sessions are designated for 10 AAPA Category 1 credits.
Each Industry-Supported Symposium is designated for 1 AAPA Category 1 credit.
PAs should only claim credit commensurate with the extent of their participation.
NURSING
The continuing nursing education live activity, GDU in Diabetic Foot General Sessions, award 10 contact hours. Provider approved by the California Board of Registered Nursing, Provider #18006 for 10 contact hours.
Each Industry-Supported Symposium is designated for 1 contact hour.
NURSE PRACTITIONERS
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
PODIATRISTS
HMP Education is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. HMP Education has approved this live activity,GDU in Diabetic Foot General Sessions, for a maximum of 10 continuing education contact hours.
HMP Education has approved each Industry-Supported Symposium activity for a maximum of 1 continuing education contact hour.
To be eligible for documentation of credit for each session attended, learners must participate in the activity and complete the session(s) and overall conference evaluations, and post-test(s), if applicable. Participants who complete the evaluation online within 30 days of the conference will receive documentation of credit. Your certificate may not load if you are accessing it from a smartphone, or settings of your browser do not allow for a new tab/window to open.
Once a certificate has been claimed, physicians and pharmacists may elect for credits to be submitted on their behalf to their boards via additional fields that will appear within the Claim Certificate page. Credits must be submitted through this process to be reported to the American Board of Surgery and the National Association of Boards of Pharmacy.
This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.
This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of HMP Education.
HMP Education complies with the legal requirement of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this education activity needs accommodation(s), please submit a request to contact the support team.
These are promotional programs and no CE credits are offered. All attendees, please be advised that information—e.g., your name and the value of any meal you receive during these promotional programs—may be publicly disclosed pursuant to applicable federal and/or state laws. If you are licensed in a state or are an employee of an organization that limits or prohibits meals from pharmaceutical companies, please identify yourself so that everyone is able to comply with such requirements.
Applications for commercial support from health care related industries are pending. Commercial support will be acknowledged as it is received.
For immediate assistance, please explore our HMP Education Help Center or chat with our Virtual CE Assistant who can answer most common questions related to claiming credits and the HMP Education website. If you have a question or grievance that cannot be answered by our Virtual CE assistant and Help Center, please submit a request to contact the support team. Our accreditation and compliance team will respond to your inquiry within 1 business day.
The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a provider-patient relationship. Medical advice of any nature should be sought from an individual’s own health care provider.
The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Global or any of its subsidiaries or affiliates. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2024 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.